Funding awarded for innovative cancer research

Thursday, 14 February 2019

Three University of Newcastle researchers have been awarded career fellowships worth more than $1.6 million for research into innovative cancer treatment.

Funded by the NSW Government and delivered through the Cancer Institute NSW, the fellowships aim to support researchers who are investigating new treatments for people with particularly aggressive forms of cancer.

Career Development Fellowship recipient, Dr Kelly Avery-Kiejda, was awarded $552,460 towards the development of a predictive test for p53 and its isoforms to aid the clinical treatment of breast cancer.

Dr Danny Lee and Dr Elizabeth Fradgley were each recognised with an Early Career Fellowship.

Dr Lee will receive $548,377 to develop his project, MIRACLE, (4D-MRI In Radiotherapy for Achieving tumour Localisation and Effective treatment).

Dr Fradgley was awarded $597,166 to continue her work on a multi-component implementation strategy to improve the evidence-based distress management practices of Australian cancer services: the effectiveness and cost of online Training and EducatioNal OutReach visits (The TENOR Trial).

Chief Cancer Officer and CEO of the Cancer Institute NSW, Professor David Currow, said the fellowships were about supporting the very best researchers to pursue promising treatments for people living with cancer.

“Their research will have an enormous, tangible impact on the community. Our goal is that it will help stop the spread of cancer and lessen its impact across the state,” Professor Currow said.

Click here to view the full list of fellowships being funded.

Related news

The University of Newcastle acknowledges the traditional custodians of the lands within our footprint areas: Awabakal, Darkinjung, Biripai, Worimi, Wonnarua, and Eora Nations. We also pay respect to the wisdom of our Elders past and present.